NGENLA
Google image searchProduct monograph
Active ingredient
somatrogon, 20 MG/ML
DIN: 02521679
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: PREFILLED PEN
Schedule: Prescription / Schedule D
Company: PFIZER CANADA ULC
Date: 22-FEB-2022
ATC:
- H01 — PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES (ATC, ATC/DDD, )
- H01A — ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES (ATC, ATC/DDD)
- H01AC — Somatropin and somatropin agonists (ATC, ATC/DDD)
- H01AC08 — SOMATROGON (ATC/DDD)
Reference brand drug: Ngenla
